Pembrolizumab as a treatment for PML?
Open Access
- 1 November 2019
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
- Vol. 6 (6), e629
- https://doi.org/10.1212/nxi.0000000000000629
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Ineffective treatment of PML with pembrolizumabNeurology Neuroimmunology & Neuroinflammation, 2019
- Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiencyNeurology Neuroimmunology & Neuroinflammation, 2019
- Treatment of Progressive Multifocal Leukoencephalopathy with PembrolizumabThe New England Journal of Medicine, 2019
- Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyThe New England Journal of Medicine, 2019
- Treatment of Progressive Multifocal Leukoencephalopathy with NivolumabThe New England Journal of Medicine, 2019
- Can Immune Checkpoint Inhibitors Keep JC Virus in Check?The New England Journal of Medicine, 2019